Anúncio
Anúncio

TOVX

TOVX logo

Theriva Biologics, Inc.

0.21
USD
Patrocinado
-0.01
-3.37%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

0.21

0.00
+1.42%

Relatórios de Lucros TOVX

Rácio de surpresa positiva

TOVX separação 33 de 39 últimas estimativas.

85%

Próximo Relatório

Data do Próximo Relatório
04 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.44
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
-2.22%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
-86.63%

Theriva Biologics, Inc. earnings per share and revenue

On 12 de nov. de 2025, TOVX reported earnings of -0.45 USD per share (EPS) for Q3 25, beating the estimate of -0.77 USD, resulting in a 41.57% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +8.05% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -0.44 USD, with revenue projected to reach -- USD, implying an diminuir of -2.22% EPS, and aumentar of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, Theriva Biologics, Inc. reported EPS of -$0.45, beating estimates by 41.57%, and revenue of $0.00, 0% as expectations.
The stock price moved up 8.05%, changed from $0.28 before the earnings release to $0.30 the day after.
The next earning report is scheduled for 04 de mar. de 2026.
Based on 4 analistas, Theriva Biologics, Inc. is expected to report EPS of -$0.44 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio